By using Affymetrix microarray technology, it was demonstrated that the Wnt/-catenin signaling pathway is the most commonly altered pathway in HCC tumors in the IQGAP2-deficient mouse model [79]. The gene discussed is IQGAP2; the disease is hepatocellular carcinoma.